Linking mRNA turnover and translation: Assessing the polyribosomal association of mRNA decay factors and degradative intermediates

被引:51
|
作者
Mangus, DA [1 ]
Jacobson, A [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA
关键词
D O I
10.1006/meth.1998.0704
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
mRNA decay is a multistep process, often dependent on the active translation of an mRNA and on components of the translation apparatus. In Saccharomyces cerevisiae, several trans-acting factors required for mRNA decay associate with polyribosomes. We have explored the specificity of the interactions of these factors with polyribosomes, using sucrose gradient sedimentation analysis of the yeast UPF1 protein to test whether such interactions are altered when polyribosomes are disrupted by treatment with EDTA, digestion with micrococcal nuclease, or shifting of cells containing a temperature-sensitive eIF3 mutation to the nonpermissive temperature. These experiments, as well as others assaying the strength of factor association in high-salt sucrose gradients, lead us to conclude that Upf1p is tightly bound to the smallest polyribosomes, but not to the 40S or 60S ribosomal subunits. Similar experimental approaches were used to determine whether mRNA decay initiates prior to mRNA release from polyribosomes. Using sucrose gradient fractionation and Northern blotting, we can detect the polysomal association of a PGK1 mRNA decay intermediate and conclude that mRNA decay commences while an mRNA is still being translated. (C) 1999 Academic Press.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 50 条
  • [31] The eukaryotic transcriptional machinery regulates mRNA translation and decay in the cytoplasm
    Dahan, Nili
    Choder, Mordechai
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2013, 1829 (01): : 169 - 173
  • [32] Dissecting mRNA decay and translation inhibition during iron deficiency
    Ramos-Alonso, Lucia
    Maria Romero, Antonia
    Polaina, Julio
    Puig, Sergi
    Teresa Martinez-Pastor, Maria
    CURRENT GENETICS, 2019, 65 (01) : 139 - 145
  • [33] Dissecting mRNA decay and translation inhibition during iron deficiency
    Lucía Ramos-Alonso
    Antonia María Romero
    Julio Polaina
    Sergi Puig
    María Teresa Martínez-Pastor
    Current Genetics, 2019, 65 : 139 - 145
  • [34] EXAMINING THE INFLUENCE OF MICRORNAS ON TRANSLATION EFFICIENCY AND ON MRNA DEADENYLATION AND DECAY
    Wu, Ligang
    Belasco, Joe G.
    RNA TURNOVER IN EUKARYOTES: ANALYSIS OF SPECIALIZED AND QUALITY CONTROL RNA DECAY PATHWAYS, 2008, 449 : 373 - 393
  • [35] Non-invasive measurement of mRNA decay reveals translation initiation as the major determinant of mRNA stability
    Chan, Leon Y.
    Mugler, Christopher F.
    Heinrich, Stephanie
    Vallotton, Pascal
    Weis, Karsten
    ELIFE, 2018, 7
  • [36] Dynamic profiling of mRNA turnover reveals gene-specific and system-wide regulation of mRNA decay
    Munchel, Sarah E.
    Shultzaberger, Ryan K.
    Takizawa, Naoki
    Weis, Karsten
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22 (15) : 2787 - 2795
  • [37] The impact of mRNA turnover and translation on age-related muscle loss
    Ma, Jennifer F.
    Hall, Derek T.
    Gallouzi, Imed-Eddine
    AGEING RESEARCH REVIEWS, 2012, 11 (04) : 432 - 441
  • [38] A dual-activity topoisomerase complex regulates mRNA translation and turnover
    Su, Shuaikun
    Xue, Yutong
    Sharov, Alexei
    Zhang, Yongqing
    Lee, Seung Kyu
    Martindale, Jennifer L.
    Li, Wen
    Ku, Wai Lim
    Zhao, Keji
    De, Supriyo
    Shen, Weiping
    Sen, Payel
    Gorospe, Myriam
    Xu, Dongyi
    Wang, Weidong
    NUCLEIC ACIDS RESEARCH, 2022, 50 (12) : 7013 - 7033
  • [39] Communication Is Key: 5′-3′ Interactions that Regulate mRNA Translation and Turnover
    Fakim, Hana
    Fabian, Marc R.
    BIOLOGY OF MRNA: STRUCTURE AND FUNCTION, 2019, 1203 : 149 - 164
  • [40] Study of the Inducible Cross-Linking Reaction to mRNA and the Effect on the Translation
    Kikuta, Kenji
    Taniguchi, Yosuke
    Sasaki, Shigeki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2019, 67 (08) : 877 - 883